U.S. FDA approves first two-drug HIV regimen in win for GSK

(Reuters) - The U.S. Food and Drug Administration has approved the first two-drug regimen to treat HIV, the virus that causes AIDS, aimed at lessening the side effect burden of current treatments that combine three or four medicines.